Between invasive surgery or risky laser therapy, people suffering from severe eye floaters have no great treatment options. Now, with the development of a safer and less invasive nanoparticle-based therapy, people with floaters may finally get their vision and quality of life back.
As the science on vaccination and natural infection-based immunity against COVID-19 variants continues to evolve, accurately communicating study results and their limitations has never been more important.
Scientists discovered that healthy epithelial cells recognize their precancerous neighbors via the expression of proteins normally only found on immune cells. The proteins that mediate this recognition between healthy and precancerous cells provide a potential new therapeutic avenue for treating cancer.
Clinicians, researchers, and communicators are developing more effective strategies to disseminate information about clinical trials to reach a wider audience. They ultimately expect that this will lead to more inclusive trials.